Nicholas Limited Edition Fund

Class Inst (NCLEX)
4 / 5 Stars
3 3 4 5 2
Zacks Investment Research
2 (Buy)
Standard & Poor's
3 / 5 Stars
D+ (Sell)

#23 in Small Growth

U.S. News evaluated 219 Small Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Nicholas funds

See full Small Growth rankings

See more fund rankings


The fund has returned 18.37 percent over the past year, 11.83 percent over the past three years, 18.44 percent over the past five years, and 9.05 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 0.0%
1 Year 18.4%
3 Years (Annualized) 11.8%
5 Years (Annualized) 18.4%
10 Years (Annualized) 9.0%

See more NCLEX performance


The investment seeks to increase the value of the investment over the long-term. The fund primarily invests in common stocks of domestic corporations with small- and medium-sized market capitalization believed to have growth potential. It believes a company's annual sales volume and market capitalization are the factors most illustrative of a company's size. The fund generally considers companies with market capitalization up to $2 billion as "small", between $2 billion and $10 billion as "medium," and greater than $10 billion as "large."


Fees are Above Average compared to funds in the same category.
Nicholas Limited Edition Fund has an expense ratio of 0.86 percent.

See more NCLEX fees


Risk is Low compared to funds in the same category according to Morningstar.

See more NCLEX risk

See Also:

Top Nicholas Funds